Carlos
González Juanatey
![Foto de Carlos](/img/nophoto.png)
![Foto de Imperial College London](/img/noimage_org.png)
Imperial College London
Londres, Reino UnidoPublications in collaboration with researchers from Imperial College London (2)
2019
-
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial
The Lancet Diabetes and Endocrinology, Vol. 7, Núm. 8, pp. 618-628
2018
-
Alirocumab and cardiovascular outcomes after acute coronary syndrome
New England Journal of Medicine, Vol. 379, Núm. 22, pp. 2097-2107